Key facts: GSK frees £2bn; $6.5B notes priced; Shingrix syringe cleared
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.